Hæmatologi

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Kilde‎: Blood Adv. 2022;6(3):785-92.

Indekseret‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (åbner nyt vindue)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (åbner nyt vindue)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Kilde‎: Transfusion 2017;57(9):2189-96.

Indekseret‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (åbner nyt vindue)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (åbner nyt vindue)

Lightdale JR, Randolph AG, Tran CM, Jiang H, Colon A, Houlahan K, Billet A, Sloan S, Lehmann LE.

Kilde‎: Biol Blood Marrow Transplant 2012;18(5):813-7.

Indekseret‎: PubMed 22080050

DOI‎: 10.1016/j.bbmt.2011.10.043

https://www.ncbi.nlm.nih.gov/pubmed/22080050 (åbner nyt vindue)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (åbner nyt vindue)

McQuilten ZK, Higgins AM, Burns K, Chunilal S, Dunstan T, Haysom HE, Kaplan Z, Rushford K, Saxby K, Tahiri R, Waters N, Wood EM.

Kilde‎: Transfusion 2019;59(11):3386-95.

Indekseret‎: PubMed 31664712

DOI‎: 10.1111/trf.15558

https://www.ncbi.nlm.nih.gov/pubmed/31664712 (åbner nyt vindue)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (åbner nyt vindue)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Kilde‎: Transfusion 2015;55(12):2807-15.

Indekseret‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (åbner nyt vindue)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (åbner nyt vindue)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Kilde‎: Cancer 2013;119(1):107-14.

Indekseret‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (åbner nyt vindue)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (åbner nyt vindue)

Nikolaidi E, Hatzikou M, Geitona M.

Kilde‎: Cost Eff Resour Alloc 2013;11(1):16.

Indekseret‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (åbner nyt vindue)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (åbner nyt vindue)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Kilde‎: Support Care Cancer 2012;20(1):159-65.

Indekseret‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (åbner nyt vindue)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (åbner nyt vindue)

Pettigrew M, Garces K, Deuson R, Kassis J, Laroche V

Kilde‎: J Med Econ 2013;16(2):318-26.

Indekseret‎: PubMed 23216012

DOI‎: 10.3111/13696998.2012.756400

https://www.ncbi.nlm.nih.gov/pubmed/23216012 (åbner nyt vindue)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (åbner nyt vindue)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Kilde‎: Hematology 2018;23(7):417-22.

Indekseret‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (åbner nyt vindue)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (åbner nyt vindue)

Reitan JF, Kudrik FJ, Fox K, van Breda A, Shreay S, Corey-Lisle PK.

Kilde‎: J Med Econ 2013;16(5):633-8.

Indekseret‎: PubMed 23425291

DOI‎: 10.3111/13696998.2013.778269

https://www.ncbi.nlm.nih.gov/pubmed/23425291 (åbner nyt vindue)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (åbner nyt vindue)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Kilde‎: Transfusion 2010;50(2):487-92.

Indekseret‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (åbner nyt vindue)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (åbner nyt vindue)

Stallworth JR, Jerrell JM, Tripathi A.

Kilde‎: Am J Hematol 2010;85(10):795-7.

Indekseret‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (åbner nyt vindue)

Increased hospital costs associated with red blood cell transfusion. (åbner nyt vindue)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Kilde‎: Transfusion 2015;55(5):1082-9.

Indekseret‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (åbner nyt vindue)

KOST/EFFEKTIVITET VED ALTERNATIVER TIL BLODTRANSFUSION

Hæmatologi

Dansk

Hæmatologi

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (åbner nyt vindue)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (åbner nyt vindue)

Restrictive blood transfusion practices are associated with improved patient outcomes. (åbner nyt vindue)

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (åbner nyt vindue)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (åbner nyt vindue)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (åbner nyt vindue)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (åbner nyt vindue)

Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. (åbner nyt vindue)

The cost of blood: a study of the total cost of red blood cell transfusion in patients with β-thalassemia using time-driven activity-based costing. (åbner nyt vindue)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (åbner nyt vindue)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (åbner nyt vindue)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (åbner nyt vindue)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (åbner nyt vindue)

Comparative net cost impact of the utilization of romiplostim and intravenous immunoglobulin for the treatment of patients with immune thrombocytopenia in Québec, Canada. (åbner nyt vindue)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (åbner nyt vindue)

The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA). (åbner nyt vindue)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (åbner nyt vindue)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (åbner nyt vindue)

Increased hospital costs associated with red blood cell transfusion. (åbner nyt vindue)

Kontaktudvalg til Hospitaler (KUH)

Informationsmateriale til sundhedspersonale

Videoer

Hæmatologi

Vælg dit sprog

Del